Suppr超能文献

精阜黏膜腺增生

Verumontanum mucosal gland hyperplasia.

作者信息

Gagucas R J, Brown R W, Wheeler T M

机构信息

Department of Pathology, Baylor College of Medicine, Houston, Texas.

出版信息

Am J Surg Pathol. 1995 Jan;19(1):30-6. doi: 10.1097/00000478-199501000-00004.

Abstract

Prostatic adenocarcinoma of the small acinar type can be mimicked by benign proliferative lesions, such as atypical adenomatous hyperplasia (adenosis), sclerosing adenosis, nodular hyperplasia (cellular areas), lobular hyperplasia, basal cell hyperplasia, mesonephric hyperplasia, and nephrogenic adenoma. In our study, we describe another microacinar proliferation, which we have termed verumontanum mucosal gland hyperplasia (VMGH) because it occurs exclusively in the verumontanum and adjacent posterior urethra where the ejaculatory ducts and utricle empty into the urethra. We reviewed 341 radical prostatectomies and cystoprostatectomies done from 1988 through 1993 for prostate and bladder carcinoma, respectively. Forty-nine prostates (14%) from patients aged 47 to 87 contained foci of VMGH. Of a total of 88 foci, a single lesion was present in 19 cases and multiple lesion in 30 cases. Fifty-nine of the foci arose around the ejaculatory or prostatic ducts, 17 from around the utricle, and 13 from adjacent posterior urethral mucosa. Individual lesions were quantified as to the number of acini per focus as follows: 6 to 10 in 28 (1+), 11 to 25 in 29 (2+), 25 to 50 in 16 (3+), and more than 50 in 15 (4+). No crystalloids or intraluminal mucin were seen, but; intraluminal corpora amylacea, usually numerous, were present in 57 of the 88 voci. The microacini were frequently "back to back" architecturally. The lining epithelium consisted of bland cuboidal to columnar luminal cells with underlying basal cells. VMGH, a previously undescribed benign microacinar proliferation, occurs in a very restricted and specific location and appears to be unrelated to other lesions with which it may be confused.

摘要

小腺泡型前列腺腺癌可被良性增生性病变所模仿,如非典型腺瘤样增生(腺病)、硬化性腺病、结节状增生(细胞区)、小叶增生、基底细胞增生、中肾增生和肾源性腺瘤。在我们的研究中,我们描述了另一种微腺泡增生,我们将其称为精阜黏膜腺增生(VMGH),因为它仅发生在精阜以及射精管和前列腺小囊排入尿道的相邻后尿道部位。我们回顾了1988年至1993年分别因前列腺癌和膀胱癌而行的341例根治性前列腺切除术和膀胱前列腺切除术。49例年龄在47至87岁患者的前列腺(14%)含有VMGH病灶。在总共88个病灶中,19例为单个病灶,30例为多个病灶。59个病灶出现在射精管或前列腺导管周围,17个来自前列腺小囊周围,13个来自相邻的后尿道黏膜。对单个病灶的每个病灶腺泡数量进行如下量化:28个病灶(1+)为6至10个,29个病灶(2+)为11至25个,16个病灶(3+)为25至50个,15个病灶(4+)超过50个。未见结晶或管腔内黏液,但88个病灶中有57个存在通常数量较多的管腔内淀粉样小体。微腺泡在结构上常“背靠背”排列。衬里上皮由温和的立方状至柱状管腔细胞及下方的基底细胞组成。VMGH是一种先前未描述的良性微腺泡增生,发生在非常局限和特定的部位,似乎与其他可能与之混淆的病变无关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验